Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24- Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)
作者:Simone Lucarini、Mauro De Santi、Francesca Antonietti、Giorgio Brandi、Giuseppe Diamantini、Alessandra Fraternale、Maria Filomena Paoletti、Andrea Tontini、Mauro Magnani、Andrea Duranti
DOI:10.3390/molecules15064085
日期:——
5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11- b’’’]tetrai ndole (CTet), an indole-3-carbinol (I3C) metabolite endowed with anticancer properties, is poorly soluble in the solvents most frequently used in biological tests. This study indicates that the use of γ-cyclodextrin (γ-CD) avoids this problem. Formulated with γ-CD CTet is a potent inhibitor of DNA synthesis in both estrogen receptor positive (MCF-7) and estrogen receptor negative (MDA-MB-231) human breast cell lines (IC50 = 1.20 ± 0.04 μM and 1.0 ± 0.1 μM, respectively).
5,6,11,12,17,18,23,24-八氢环十二烷[1,2-b:4,5-b':7,8-b'':10,11-b''']四吲哚(CTet)是一种具有抗癌特性的吲哚-3-甲醇(I3C)代谢物,在生物测试中最常用的溶剂中溶解度很低。本研究表明,使用γ-环糊精(γ-CD)可避免这一问题。用 γ-CD 配制的 CTet 是雌激素受体阳性(MCF-7)和雌激素受体阴性(MDA-MB-231)人类乳腺细胞系 DNA 合成的强效抑制剂(IC50 分别为 1.20 ± 0.04 μM 和 1.0 ± 0.1 μM)。